We are live on !
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
(+10%)
Cap. Flow
+$81.1M
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held
Equity + Options
0.3
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
Abbott
ABT
|
+$125M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$121M |
| 4 |
SpaceX
SPCX
|
+$116M |
| 5 |
Procter & Gamble
PG
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$128M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$111M |
| 3 |
Elastic
ESTC
|
+$110M |
| 4 |
Twilio
TWLO
|
+$110M |
| 5 |
Intuitive Surgical
ISRG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Financials | 16.81% |
| 3 | Miscellaneous | 15.64% |
| 4 | Technology | 13.57% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
451
SiriusXM
SIRI
$9.09B
| $1.63M | 0.01% |
55,025
+41,182
| +297% | +$1.11M |
2025 Q4
2 quarters
|
|
452
Alamar Biosciences
ALMR
$2.18B
| $1.63M | 0.01% |
+60,000
| New | +$1.36M |
2026 Q2
0 quarters
|
|
453
PagerDuty
PD
$1.34B
| $1.62M | 0.01% |
167,570
+10,402
| +7% | +$78.7K |
2025 Q1
5 quarters
|
|
454
Collegium Pharmaceutical
COLL
$746M
| $1.61M | 0.01% |
44,493
-14,153
| -24% | -$484K |
2025 Q3
3 quarters
|
|
455
Zillow
Z
$7.04B
| $1.6M | 0.01% |
50,821
+33,600
| +195% | +$1.29M |
2025 Q4
2 quarters
|
|
456
Labcorp
LH
$26.3B
| $1.58M | 0.01% |
5,653
+1,940
| +52% | +$510K |
2026 Q1
1 quarter
|
|
457
CareTrust REIT
CTRE
$8.42B
| $1.58M | 0.01% |
+39,113
| New | +$1.54M |
2026 Q2
0 quarters
|
|
458
Freshpet
FRPT
$3.01B
| $1.58M | 0.01% |
+26,669
| New | +$1.53M |
2026 Q2
0 quarters
|
|
459
Olin
OLN
$1.7B
| $1.56M | 0.01% |
+78,815
| New | +$2.06M |
2026 Q2
0 quarters
|
|
460
California Water Service
CWT
$2.84B
| $1.55M | 0.01% |
31,950
+11,426
| +56% | +$515K |
2025 Q1
5 quarters
|
|
461
Insulet
PODD
$9.8B
| $1.54M | 0.01% |
10,140
-216,420
| -96% | -$36.1M |
2024 Q4
6 quarters
|
|
462
Greif
GEF
$4.66B
| $1.53M | 0.01% |
20,603
+15,760
| +325% | +$1.06M |
2026 Q1
1 quarter
|
|
463
Ameren
AEE
$29.5B
| $1.53M | 0.01% |
13,548
-185,151
| -93% | -$20.5M |
2025 Q4
2 quarters
|
|
464
Gartner
IT
$13.9B
| $1.53M | 0.01% |
+11,805
| New | +$1.78M |
2026 Q2
0 quarters
|
|
465
ResMed
RMD
$34.6B
| $1.53M | 0.01% |
+7,826
| New | +$1.62M |
2026 Q2
0 quarters
|
|
466
Equity Lifestyle Properties
ELS
$11.5B
| $1.52M | 0.01% |
23,648
-84,094
| -78% | -$5.31M |
2026 Q1
1 quarter
|
|
467
GATX Corp
GATX
$5.8B
| $1.51M | 0.01% |
+8,524
| New | +$1.55M |
2026 Q2
0 quarters
|
|
468
Strategic Education
STRA
$1.77B
| $1.51M | 0.01% |
19,657
+16,634
| +550% | +$1.32M |
2026 Q1
1 quarter
|
|
469
Northern Oil and Gas
NOG
$2.92B
| $1.49M | 0.01% |
82,063
+47,168
| +135% | +$1.12M |
2026 Q1
1 quarter
|
|
470
Alarm.com
ALRM
$2.92B
| $1.47M | 0.01% |
31,450
+21,793
| +226% | +$977K |
2025 Q2
4 quarters
|
|
471
Walker & Dunlop
WD
$1.13B
| $1.46M | 0.01% |
26,724
-9,136
| -25% | -$463K |
2025 Q3
3 quarters
|
|
472
CarGurus
CARG
$2.78B
| $1.46M | 0.01% |
42,790
+9,976
| +30% | +$323K |
2026 Q1
1 quarter
|
|
473
Sabra Healthcare REIT
SBRA
$4.83B
| $1.44M | 0.01% |
74,058
-1,393,635
| -95% | -$27.6M |
2025 Q4
2 quarters
|
|
474
Albemarle
ALB
$11.1B
| $1.43M | 0.01% |
+10,614
| New | +$1.87M |
2026 Q2
0 quarters
|
|
475
Halozyme
HALO
$14.2B
| $1.42M | 0.01% |
18,192
-2,527
| -12% | -$172K |
2025 Q4
2 quarters
|
|
Similar funds
Freestone Grove Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.
- Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
- Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
- Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
- Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
- Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
- Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
- Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.